Related Experiment Video
Updated: Jan 7, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Multimodal Therapy for Pancreatic Cancer: State of the Art
Tia S Sutton1, Annmarie F Butare2, David B Meyer3
1Community Surgical Oncology Program, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
None:
The mainstay treatment for pancreatic cancer has classically been surgical resection. However, with the adoption of multimodal therapy, the 5-year survival rates have improved from 5% to 10% over the past 2 decades. Thanks to robust clinical trials, there is strong evidence to support the use of adjuvant chemoradiation for pancreatic cancer. Neoadjuvant therapy (NAT), however, is emerging as a potential strategy to further improve survival and outcomes. The purpose of this review is to provide a historical background of the use of multimodal therapy in the treatment of pancreatic cancer, as well as to explore the latest clinical questions regarding NAT in pancreatic cancer treatment. This article reviews the latest evidence in neoadjuvant treatment, discusses ongoing clinical trials, and provides insight on future directions of multimodal therapy for pancreatic cancer.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy

